Nxera Pharma Co., Ltd. (SOLTF) Financials
SOLTF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 861.1 million | 471.4 million |
| Sept. 30, 2025 | 988.1 million | 538.1 million |
| June 30, 2025 | 1.0 billion | 548.1 million |
| March 31, 2025 | 975.4 million | 526.4 million |
SOLTF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -1.7 million | ? |
| Sept. 30, 2025 | -21.1 million | ? |
| June 30, 2025 | -1.9 million | -2.7 million |
| March 31, 2025 | 3.4 million | 2.6 million |
SOLTF Net Income
No data available :(
SOLTF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 130.1 million | 346.3 million | 22.4 million |
| Sept. 30, 2025 | 195.1 million | 387.0 million | 19.6 million |
| June 30, 2025 | 229.7 million | 403.6 million | 27.4 million |
| March 31, 2025 | 230.8 million | 398.9 million | 27.5 million |
SOLTF Shares Outstanding
SOLTF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 939162 | 20.9 million | 24.4 million | - |
| Sept. 30, 2025 | 695941 | 25.5 million | 26.3 million | - |
| June 30, 2025 | 625827 | 25.5 million | 26.9 million | - |
| March 31, 2025 | 729797 | 25.5 million | 24.8 million | - |
SOLTF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 49.6 million | 13.1 million |
| Sept. 30, 2025 | 46.3 million | 18.3 million |
| June 30, 2025 | 58.8 million | 12.9 million |
| March 31, 2025 | 44.5 million | 10.8 million |
SOLTF
Price: $6.18
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.89 USD
P/E Ratio: -6.11
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 642.1 million